• Megimmuno Swiss Pharmaceutical Technologies SA

    FR
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-550.1.155.349-2
    Sector: Research and development

    Age of the company

    10 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    120'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Megimmuno Swiss Pharmaceutical Technologies SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company. Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices. Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings. Find out more

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Megimmuno Swiss Pharmaceutical Technologies SA

    • Megimmuno Swiss Pharmaceutical Technologies SA with its legal headquarters in Villaz-St-Pierre is a Company limited by shares (AG) from the sector «Research and development». Megimmuno Swiss Pharmaceutical Technologies SA is active.
    • The management has one active person registered.
    • On the 08.01.2020 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The company is registered in the commercial register of the Canton of FR under the UID CHE-280.777.119.
    • On the same address there are 17 other active companies registered. These include: AlloDéchets Sàrl, asyril SA, BEG SA Géologie & Environnement, succursale de Villaz (FR).

    Management (1)

    newest board members

    Valeriy Surovtsev

    newest authorized signatories

    Valeriy Surovtsev

    Source: SOGC

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language) Customise the company purpose with just a few clicks.

    La société a pour but la recherche, le développement, la promotion, la production/fabrication et la commercialisation de produits pharmaceutiques, biologiques ou similaires, en particulier dans le domaine de l'industrie de la santé, ainsi que la fourniture de tous services relatifs (pour but complet cf. statuts).

    Other company names

    Source: SOGC

    Past and translated company names

    • Megimmuno Swiss Pharmaceutical Technologies Ltd
    • Megimmuno Swiss Pharmaceutical Technologies AG
    Would you like to update the company name? Click here.

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Megimmuno Swiss Pharmaceutical Technologies SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 200108/2020 - 08.01.2020
    Categories: Change of company address

    Publication number: HR02-1004798110, Commercial Registry Office Fribourg, (217)

    Megimmuno Swiss Pharmaceutical Technologies SA, à Villaz-Saint-Pierre, CHE-280.777.119 (FOSC du 21.04.2017, p. 0/3479505). Inscription d'office par suite de la fusion des communes de La Folliaz et Villaz-Saint-Pierre entrée en vigueur le 01.01.2020.

    Nouvelle dénomination du siège:
    Villaz.

    SOGC 77/2017 - 21.04.2017
    Categories: Change in capital

    Publication number: 3479505, Commercial Registry Office Fribourg, (217)

    Megimmuno Swiss Pharmaceutical Technologies SA, à Villaz-Saint-Pierre, CHE-280.777.119 (FOSC du 26.05.2016, p. 0/2853025).

    Augmentation ordinaire:
    Capital-actions porté de CHF 100'000 à CHF 120'000 par l'émission de 2'000'000 actions de CHF 0.01, entièrement libérées en espèces.

    Capital-actions actuel:
    CHF 120'000, entièrement libéré, divisé en 12'000'000 actions de CHF 0.01, nominatives et liées selon les statuts. Statuts modifiés le 13.04.2017.

    SOGC 100/2016 - 26.05.2016
    Categories: Change of company address

    Publication number: 2853025, Commercial Registry Office Fribourg, (217)

    Megimmuno Swiss Pharmaceutical Technologies SA [Megimmuno Swiss Pharmaceutical Technologies AG] [Megimmuno Swiss Pharmaceutical Technologies Ltd], précédemment à Lausanne, CHE-280.777.119 (FOSC du 08.06.2015, p. 0/2193683). Siège transféré à Villaz-Saint-Pierre, Zone Industrielle Le Vivier 22, c/o Vivier SA, 1690 Villaz-St-Pierre. Statuts originaires du 07.08.2014, modifiés le 19.05.2015.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm